A top ten Japanese pharma had extremely urgent and high-profile clinical trials for both a vaccine and a therapy in response to the COVID-19 pandemic. The team had to ensure data quality remained uncompromised whilst operating in an environment where limited site visits were permitted.

Flexibility to Respond

The use of the CluePoints solutions enabled this pharma to ensure data quality whilst retaining the flexibility to modify trial structure and to resolve any issues that arose during the trials. Both trials are ongoing and together with both CluePoints and the client, we strive every day to ensure the successful outcome.